Editors' ChoiceCancer

Paper of note in Science Translational Medicine 9 (398)

See allHide authors and affiliations

Science Signaling  18 Jul 2017:
Vol. 10, Issue 488, eaao3798
DOI: 10.1126/scisignal.aao3798

This week’s article describes an epigenetic target for treating kidney cancer.


An “EZ” target for kidney cancer

Chakraborty et al. discovered that inhibiting the histone methyltransferase EZH1 might kill tumor cells in patients with VHL-deficient clear cell renal cell carcinoma.

Highlighted Article

Stay Connected to Science Signaling

Navigate This Article